PAG
PAG is an independent, Asia-focused alternative investment management firm founded in 2002 and based in Hong Kong, with offices across Asia, Australia, the United Kingdom and Switzerland. It manages capital across three core strategies: private equity, real estate and absolute return investments. In private equity, PAG pursues large-scale buyouts, control transactions and structured minority investments, with a preference for opportunities in financial services, healthcare, information technology, media, telecommunications, education and consumer sectors, often targeting investments in China. In real estate, it runs funds that pursue opportunity and core-plus properties across Japan, China and the broader Asia-Pacific region. The absolute return franchise provides flexible financing solutions to meet short- and long-term needs and aims to build stable partnerships over time. Originating as the Pacific Alliance Group, PAG positioned itself as one of the region's leading Asia-focused investment managers, combining independent management with a broad geographic reach.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Sujey Subramanian
Managing Director, Deputy Chief Investment Officer and Head of Southeast Asia at PAG Asia Capita
Past deals in Hong Kong
Prenetics Limited
Post in 2022
Prenetics Limited is a biotechnology company specializing in pharmacogenomics and genetic testing. Established in Hong Kong in 2007, the company offers iGenes PGx test to help physicians tailor drug treatments based on patients' genetic profiles, covering cardiovascular, psychiatric, pain, hypersensitivity, and commonly prescribed drugs. Additionally, Prenetics provides ONEdna, a DNA screening service offering gene analysis and actionable recommendations.
Yingde Gases
Private Equity Round in 2017
Yingde Gases Group Company Limited (Yingde Gases) is a large-scale and professional company, dedicating to the national development of industrial gases. The major businesses of us are on-site gas supply, retailed gas distribution, specialized production of industrial gases like Oxygen, Nitrogen, Argon and some specialty gases. Their customers are mainly from iron and steel, chemical, non-ferrous metals, electronics, energy industries.
Yingde Gases was established in October 2001. After 10 years of development, it has become the largest gas service company in China. Yingde Gases (Stock Code: 02168.HK) was listed on the main board of Hong Kong Stock Exchange on 8th October, 2009.The Company stock became the constituents of the Hang Seng Composite Index(HSCI) ,the Hang Seng Mainland 100 on 8th March,2010 and that of the Morgan Stanley Capital International (MSCI) China Index in November 2011.
Bicon Pharmaceutical Holdings
Private Equity Round in 2012
Bicon Pharmaceutical Holdings is a large-scale pharmaceutical enterprise founded in 1997 that engages in the manufacturing and provision of various medicinal products. The company specializes in pharmaceutical raw materials, modern Chinese patent medicines, generic drugs, biological agents, and vaccine research and development, as well as their production and marketing. Bicon's production facilities span 7.33 hectares and include the largest monomer workshop in Asia, which adheres to good manufacturing practice standards. The site features extensive sterilization space and operates 15 production lines capable of producing a wide range of products, such as tablets, capsules, and injections, with an impressive annual production capacity exceeding RMB 6 billion. Additionally, Bicon operates a herbal medicine extraction workshop with an annual capacity of 8,000 tons. As a foreign-owned enterprise, it is held by Hong Kong Bicon International, with a registered capital of RMB 937 million.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.